- Home
- MVST vs FENC Comparison
MVST vs FENC Comparison
Compare MVST & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- FENC
- Stock Information
- Founded
- MVST 2006
- FENC 1996
- Country
- MVST United States
- FENC United States
- Employees
- MVST N/A
- FENC N/A
- Industry
- MVST Industrial Machinery/Components
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MVST Miscellaneous
- FENC Health Care
- Exchange
- MVST Nasdaq
- FENC Nasdaq
- Market Cap
- MVST 848.0M
- FENC 234.9M
- IPO Year
- MVST N/A
- FENC 2001
- Fundamental
- Price
- MVST $5.60
- FENC $8.58
- Analyst Decision
- MVST Strong Buy
- FENC Strong Buy
- Analyst Count
- MVST 1
- FENC 2
- Target Price
- MVST $6.00
- FENC $13.50
- AVG Volume (30 Days)
- MVST 11.3M
- FENC 77.3K
- Earning Date
- MVST 11-11-2025
- FENC 11-06-2025
- Dividend Yield
- MVST N/A
- FENC N/A
- EPS Growth
- MVST N/A
- FENC N/A
- EPS
- MVST N/A
- FENC N/A
- Revenue
- MVST $422,605,000.00
- FENC $33,302,000.00
- Revenue This Year
- MVST $24.21
- FENC $0.18
- Revenue Next Year
- MVST $31.67
- FENC $52.59
- P/E Ratio
- MVST N/A
- FENC N/A
- Revenue Growth
- MVST 20.84
- FENC N/A
- 52 Week Low
- MVST $0.15
- FENC $3.96
- 52 Week High
- MVST $7.12
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- MVST 63.73
- FENC 46.13
- Support Level
- MVST $5.73
- FENC $8.24
- Resistance Level
- MVST $6.24
- FENC $8.90
- Average True Range (ATR)
- MVST 0.56
- FENC 0.41
- MACD
- MVST 0.09
- FENC -0.09
- Stochastic Oscillator
- MVST 48.48
- FENC 21.35
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.